Principal Financial Group Inc. acquired a new position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 22,143 shares of the company’s stock, valued at approximately $149,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock valued at $19,548,000 after purchasing an additional 41,515 shares during the period. AltraVue Capital LLC raised its position in shares of SIGA Technologies by 6.6% during the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock valued at $16,528,000 after buying an additional 134,450 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of SIGA Technologies by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 1,821,788 shares of the company’s stock valued at $13,826,000 after buying an additional 133,883 shares during the period. American Century Companies Inc. grew its position in SIGA Technologies by 251.2% during the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock worth $6,389,000 after buying an additional 602,091 shares in the last quarter. Finally, General American Investors Co. Inc. increased its stake in SIGA Technologies by 0.7% during the second quarter. General American Investors Co. Inc. now owns 746,646 shares of the company’s stock valued at $5,667,000 after acquiring an additional 4,919 shares during the period. Institutional investors own 55.40% of the company’s stock.
SIGA Technologies Stock Up 12.8 %
SIGA Technologies stock opened at $7.31 on Tuesday. SIGA Technologies, Inc. has a 12 month low of $4.26 and a 12 month high of $12.83. The stock has a market cap of $521.93 million, a price-to-earnings ratio of 6.09 and a beta of 0.89. The business has a 50 day moving average price of $7.02 and a two-hundred day moving average price of $7.86.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Recommended Stories
- Five stocks we like better than SIGA Technologies
- Investing in Construction Stocks
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What is a buyback in stocks? A comprehensive guide for investors
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- 10 Best Airline Stocks to Buy
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.